Marco Ruella

Person

Philadelphia, PA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Nucleic acid molecules encoding chimeric antigen receptors comprisi...
- Patent number RE49847
- Issue date Feb 27, 2024
- Novartis AG
- Barbara Brannetti
Information Patent Grant
Method of treating cancer by administering immune effector cells ex...
- Patent number 11,872,249
- Issue date Jan 16, 2024
- Novartis AG
- Barbara Brannetti
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of CD2/5/7 knock-out anti-CD2/5/7 chimeric antigen receptor T c...
- Patent number 11,673,964
- Issue date Jun 13, 2023
- The Trustees of the University of Pennsylvania
- Marco Ruella
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer using a CD123 chimeric antigen receptor
- Patent number 11,591,404
- Issue date Feb 28, 2023
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
CD20 therapies, CD22 therapies, and combination therapies with a CD...
- Patent number 11,149,076
- Issue date Oct 19, 2021
- Novartis AG
- Hans Bitter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-BCMA chimeric antigen receptor
- Patent number 11,084,880
- Issue date Aug 10, 2021
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Nucleic acid molecules encoding chimeric antigen receptors comprisi...
- Patent number 11,026,976
- Issue date Jun 8, 2021
- Novartis AG
- Barbara Brannetti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer using a CD123 chimeric antigen receptor
- Patent number 10,703,819
- Issue date Jul 7, 2020
- The Trustees of the University of Pennsylvania
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer using anti-CD19 Chimeric Antigen Receptor
- Patent number 10,357,514
- Issue date Jul 23, 2019
- The Trustees of the University of Pennsylvania
- Carl H. June
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
CD20 therapies, CD22 therapies, and combination therapies with a CD...
- Patent number 10,253,086
- Issue date Apr 9, 2019
- Novartis AG
- Hans Bitter
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor
- Patent number 10,174,095
- Issue date Jan 8, 2019
- Novartis AG
- Jennifer Brogdon
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of cancer using a CD123 chimeric antigen receptor
- Patent number 9,815,901
- Issue date Nov 14, 2017
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
MODULATION OF BCL-2 TO ENHANCE CHIMERIC ANTIGEN RECEPTOR CANCER IMM...
- Publication number 20240335539
- Publication date Oct 10, 2024
- The Trustees of the University of Pennsylvania
- Marco Ruella
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND COMPOSITIONS FOR PREDICTING CANCER SURVIVAL AND CAR T C...
- Publication number 20240293481
- Publication date Sep 5, 2024
- Memorial Sloan-Kettering Cancer Center
- Melody Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRISPR-Cas9 Knock-out of SHP-1/2 to Reduce T cell Exhaustion in Ado...
- Publication number 20240271090
- Publication date Aug 15, 2024
- The Trustees of the University of Pennsylvania
- Marco RUELLA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF CANCER USING CHIMERIC ANTIGEN RECEPTORS
- Publication number 20240252538
- Publication date Aug 1, 2024
- Novartis AG
- Barbara Brannetti
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Use of CD2/5/7 Knock-Out Anti-CD2/5/7 Chimeric Antigen Receptor T c...
- Publication number 20240228655
- Publication date Jul 11, 2024
- The Trustees of the University of Pennsylvania
- Marco RUELLA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD...
- Publication number 20230374105
- Publication date Nov 23, 2023
- Novartis AG
- Hans Bitter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of CD2/5/7 Knock-Out Anti-CD2/5/7 Chimeric Antigen Receptor T c...
- Publication number 20230331864
- Publication date Oct 19, 2023
- The Trustees of the University of Pennsylvania
- Marco RUELLA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20230220090
- Publication date Jul 13, 2023
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NUCLEIC ACID MOLECULES ENCODING CHIMERIC ANTIGEN RECEPTORS COMPRISI...
- Publication number 20220387486
- Publication date Dec 8, 2022
- Novartis AG
- Barbara Brannetti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD...
- Publication number 20220195010
- Publication date Jun 23, 2022
- Novartis AG
- Hans Bitter
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Use of CD2/5/7 Knock-Out Anti-CD2/5/7 Chimeric Antigen Receptor T c...
- Publication number 20220073639
- Publication date Mar 10, 2022
- The Trustees of the University of Pennsylvania
- Marco RUELLA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CANCER USING HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RECE...
- Publication number 20220064316
- Publication date Mar 3, 2022
- The Trustees of the University of Pennsylvania
- Jennifer Brogdon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPY WITH CHIMERIC ANTIGEN RECEPTOR (CAR) THERAPIES
- Publication number 20210213063
- Publication date Jul 15, 2021
- Novartis AG
- Randi Isaacs
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CAR COMPOSITIONS AND METHODS
- Publication number 20210179709
- Publication date Jun 17, 2021
- Novartis AG
- Saar Gill
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20210002377
- Publication date Jan 7, 2021
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND COMPOSITIONS COMPRISING CART AND A SMAC MIMETIC
- Publication number 20200376035
- Publication date Dec 3, 2020
- The Trustees of the University of Pennsylvania
- Marco Ruella
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRISPR-Cas9 Knock-out of SHP-1/2 to Reduce T cell Exhaustion in Ado...
- Publication number 20200080056
- Publication date Mar 12, 2020
- The Trustees of the University of Pennsylvania
- Marco RUELLA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20190388471
- Publication date Dec 26, 2019
- Novartis AG
- Carl H. June
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT AND PREVENTION OF CYTOKINE RELEASE SYNDROME USING A CHIME...
- Publication number 20190336504
- Publication date Nov 7, 2019
- Novartis AG
- Saar Gill
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD...
- Publication number 20190292238
- Publication date Sep 26, 2019
- Novartis AG
- Hans Bitter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING A CHIMERIC ANTIGEN RECEPTOR IN COMBINATIO...
- Publication number 20190161542
- Publication date May 30, 2019
- Novartis AG
- Saar Gill
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING 5 HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RE...
- Publication number 20190153061
- Publication date May 23, 2019
- Novartis AG
- Jennifer Brogdon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20180312595
- Publication date Nov 1, 2018
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMBINATION OF CHIMERIC ANTIGEN RECEPTOR THERAPY AND AMINO PYRIMIDI...
- Publication number 20180140602
- Publication date May 24, 2018
- Novartis AG
- Daniela Angst
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD...
- Publication number 20160362472
- Publication date Dec 15, 2016
- Hans Bitter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20160068601
- Publication date Mar 10, 2016
- The Trustees of the University of Pennsylvania
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RECE...
- Publication number 20160046724
- Publication date Feb 18, 2016
- The Trustees of the University of Pennsylvania
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20150283178
- Publication date Oct 8, 2015
- Carl H. June
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Marco Ruella

Person

Patents Grantslast 30 patents

Nucleic acid molecules encoding chimeric antigen receptors comprisi...

Method of treating cancer by administering immune effector cells ex...

Use of CD2/5/7 knock-out anti-CD2/5/7 chimeric antigen receptor T c...

Treatment of cancer using a CD123 chimeric antigen receptor

CD20 therapies, CD22 therapies, and combination therapies with a CD...

Anti-BCMA chimeric antigen receptor

Nucleic acid molecules encoding chimeric antigen receptors comprisi...

Treatment of cancer using a CD123 chimeric antigen receptor

Treatment of cancer using anti-CD19 Chimeric Antigen Receptor

CD20 therapies, CD22 therapies, and combination therapies with a CD...

Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor

Treatment of cancer using a CD123 chimeric antigen receptor

Patents Applicationslast 30 patents

MODULATION OF BCL-2 TO ENHANCE CHIMERIC ANTIGEN RECEPTOR CANCER IMM...

METHODS AND COMPOSITIONS FOR PREDICTING CANCER SURVIVAL AND CAR T C...

CRISPR-Cas9 Knock-out of SHP-1/2 to Reduce T cell Exhaustion in Ado...

TREATMENT OF CANCER USING CHIMERIC ANTIGEN RECEPTORS

Use of CD2/5/7 Knock-Out Anti-CD2/5/7 Chimeric Antigen Receptor T c...

CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD...

Use of CD2/5/7 Knock-Out Anti-CD2/5/7 Chimeric Antigen Receptor T c...

TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR

NUCLEIC ACID MOLECULES ENCODING CHIMERIC ANTIGEN RECEPTORS COMPRISI...

CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD...

Use of CD2/5/7 Knock-Out Anti-CD2/5/7 Chimeric Antigen Receptor T c...

TREATMENT OF CANCER USING HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RECE...

COMBINATION THERAPY WITH CHIMERIC ANTIGEN RECEPTOR (CAR) THERAPIES

ANTI-CAR COMPOSITIONS AND METHODS

TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR

METHODS AND COMPOSITIONS COMPRISING CART AND A SMAC MIMETIC

CRISPR-Cas9 Knock-out of SHP-1/2 to Reduce T cell Exhaustion in Ado...

TREATMENT OF CANCER USING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR

TREATMENT AND PREVENTION OF CYTOKINE RELEASE SYNDROME USING A CHIME...

CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD...

TREATMENT OF CANCER USING A CHIMERIC ANTIGEN RECEPTOR IN COMBINATIO...

TREATMENT OF CANCER USING 5 HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RE...

TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR

COMBINATION OF CHIMERIC ANTIGEN RECEPTOR THERAPY AND AMINO PYRIMIDI...

CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD...

TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR

TREATMENT OF CANCER USING HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RECE...

TREATMENT OF CANCER USING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR